Evidence map›Paper›PMID 33107322›Full record

ArticleJournal of cardiovascular pharmacology and therapeutics2021

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors.

Patricia P Wadowski, Joseph Pultar, Constantin Weikert, Beate Eichelberger, Irene M Lang, Renate Koppensteiner, Simon Panzer, Thomas Gremmel

Open access · hybridAbstract read
In one paragraph

Article in Journal of cardiovascular pharmacology and therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Frontiers in pharmacology · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Patricia P WadowskiDepartment of Internal Medicine II, 27271Medical University of Vienna, Vienna, Austria.
Joseph PultarDepartment of Internal Medicine II, 27271Medical University of Vienna, Vienna, Austria.
Constantin WeikertDepartment of Internal Medicine II, 27271Medical University of Vienna, Vienna, Austria.
Beate EichelbergerDepartment of Blood Group Serology and Transfusion Medicine, 27271Medical University of Vienna, Vienna, Austria.
Irene M LangDepartment of Internal Medicine II, 27271Medical University of Vienna, Vienna, Austria.
Renate KoppensteinerDepartment of Internal Medicine II, 27271Medical University of Vienna, Vienna, Austria.
Simon PanzerDepartment of Blood Group Serology and Transfusion Medicine, 27271Medical University of Vienna, Vienna, Austria.
Thomas GremmelDepartment of Internal Medicine II, 27271Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-9554-7292
Medical University of Vienna · ATLandesklinikum Korneuburg · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since data on the agreement between light transmission aggregometry (LTA) and multiple electrode aggregometry (MEA) in patients on the more potent P2Y

Indexed as

AgedAspirinDual Anti-Platelet TherapyFemaleHumansMaleMiddle AgedPlatelet Aggregation InhibitorsPlatelet Function TestsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsSensitivity and SpecificityTicagrelorAspirinPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsTicagrelorantiplatelet therapyhigh on-treatment residual platelet reactivitylight transmission aggregometrymultiple electrode aggregometryP2Y12 antagonists

Identifiers

PMID33107322
PMCPMC8010888
OpenAlexW3094419805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.